These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3261188)

  • 1. Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
    Pease PE; Lane MR; Chahal H; Tallack JE; Allan RN
    Br J Rheumatol; 1988; 27 Suppl 2():29-31. PubMed ID: 3261188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases.
    van den Berg-Loonen EM; Dekker-Saeys BJ; Meuwissen SG; Nijenhuis LE; Engelfriet CP
    J Immunogenet; 1977 Jun; 4(3):167-75. PubMed ID: 901632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).
    Mallas EG; Mackintosh P; Asquith P; Cooke WT
    Gut; 1976 Nov; 17(11):906-10. PubMed ID: 1001980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.
    Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Meijers KA; Tytgat GN
    Ann Rheum Dis; 1978 Feb; 37(1):36-41. PubMed ID: 629602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations upon HLA-B27, Yersinia enterocolitica, and ankylosing spondylitis.
    Pease PE; Balmer SE; Tallack JE; Chahal H; Ibbotson J; Bartlett LR; Lane M; Allan RN
    Ann Rheum Dis; 1986 Jun; 45(6):526-8. PubMed ID: 3488038
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility antigens and other markers in ankylosing spondylitis and inflammatory bowel diseases.
    van dan Berg-Loonen PM; Dekker-Saeys AJ; Meuwissen SG; Nijenhuis LE
    J Rheumatol Suppl; 1977; 3():57-9. PubMed ID: 266599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27 and clinical aspects of ankylosing spondylitis: results of prospective studies.
    Wagener P; Mau W; Zeidler H; Eckert G; Robin-Winn M; Deicher H
    Immunol Rev; 1985 Aug; 86():93-100. PubMed ID: 3899917
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.
    Tiwana H; Wilson C; Walmsley RS; Wakefield AJ; Smith MS; Cox NL; Hudson MJ; Ebringer A
    Rheumatol Int; 1997; 17(1):11-6. PubMed ID: 9194209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
    Dequeker J; Decock T; Walravens M; Van de Putte I
    J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of cross-reaction between HLA B27 and yersinia enterocolitica or chlamydia trachomatis in reactive arthritis and ankylosing spondylitis.
    Roudier J; De Montclos H; Thouvenot D; Chomel JJ; Guillermet FN; Betuel H
    Clin Rheumatol; 1985 Dec; 4(4):487. PubMed ID: 3879474
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte proliferative responses to bacterial antigens in B27-associated arthropathies.
    Sheldon PJ; Pell PA
    Br J Rheumatol; 1985 Feb; 24(1):11-8. PubMed ID: 3919798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
    Singh B; Milton JD; Woodrow JC
    Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia enterocolitica biotype I. Diarrhoea and episodes of HLA B27 related ocular and rheumatic inflammatory disease in South-East England.
    Ebringer R; Colthorpe D; Burden G; Hindley C; Ebringer A
    Scand J Rheumatol; 1982; 11(3):171-6. PubMed ID: 6981842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
    Kobayashi S; Ogasawara M; Maeda K; Yu DT
    J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.
    Kono DH; Ogasawara M; Effros RB; Park MS; Waldord RL; Yu DT
    Clin Exp Immunol; 1985 Sep; 61(3):503-8. PubMed ID: 3878239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Botelberghe L
    J Rheumatol; 1985 Apr; 12(2):294-8. PubMed ID: 3875721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seronegative arthritis associated with serological evidence of Yersinia infection in Australia.
    Wakefield D; Stahlberg T; Freston J; Buckley R
    Aust N Z J Med; 1989 Aug; 19(4):331-3. PubMed ID: 2789509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA B27 in regional enteritis with and without ankylosing spondylitis or sacroiliitis.
    Huaux JP; Fiasse R; De Bruyere M; Nagant de Deuxchaisnes C
    J Rheumatol Suppl; 1977; 3():60-3. PubMed ID: 266600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.